These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19844875)

  • 21. [Heart failure in hypertension in the elderly].
    Seto S
    Nihon Rinsho; 2005 Jun; 63(6):1041-6. PubMed ID: 15948388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive therapy and drug-drug interactions].
    Girardin F; Pechère-Bertschi A
    Rev Med Suisse; 2005 Sep; 1(32):2099-100, 2102-4. PubMed ID: 16238231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arterial hypertension and cardiac decompensation].
    Degaute JP
    Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
    Carroll C; Hassanin A
    JAMA Intern Med; 2017 Jun; 177(6):871. PubMed ID: 28437544
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of antihypertensive drugs in France and relationship with cardiovascular disease. FLAHS 2009-2010 surveys].
    Girerd X; Laroche P; Hanon O; Pannier B; Postel-Vinay N; Mourad JJ
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):213-7. PubMed ID: 22695024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiomyopathy and calciphylaxis in a patient with normal renal function: a case report.
    Kolli S; Douglas J; Doumit E; Guglin M
    Congest Heart Fail; 2010; 16(2):71-2. PubMed ID: 20412472
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].
    Knauf H; Mutschler E
    MMW Munch Med Wochenschr; 1983 Nov; 125(45):1037-40. PubMed ID: 6139750
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure].
    Di Lenarda A
    Ital Heart J Suppl; 2000 Aug; 1(8):1063-5. PubMed ID: 10993017
    [No Abstract]   [Full Text] [Related]  

  • 31. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
    Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [COMET: metoprolol].
    Handa S
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():521-5. PubMed ID: 17511103
    [No Abstract]   [Full Text] [Related]  

  • 34. Back to basics: diuretics as first-line agents in the treatment of hypertension.
    Mandal VJ
    J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664
    [No Abstract]   [Full Text] [Related]  

  • 35. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 38. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
    Wikstrand J; Ghali JK; Goldstein S
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological treatment of systolic heart failure.
    Liedholm H; Linné AB; Merlo J
    Lancet; 1999 Oct; 354(9188):1471-2. PubMed ID: 10543692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.